Spectrum Pharmaceuticals

Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee
Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee
Marketwatch
Spectrum Pharmaceuticals
FDA
Qapzola
cancer
Flag link:
Spectrum's once-rejected cancer drug wins FDA approval
Spectrum's once-rejected cancer drug wins FDA approval
Fierce Biotech
Spectrum Pharmaceuticals
FDA
Evomela
Flag link:
Spectrum Pharmaceuticals reports 3rd-quarter loss but tops expectations
Spectrum Pharmaceuticals reports 3rd-quarter loss but tops expectations
Yahoo/AP
Spectrum Pharmaceuticals
earnings
Flag link:
Spectrum says U.S. FDA declines to approve Evomela for injection
Spectrum says U.S. FDA declines to approve Evomela for injection
Yahoo/Reuters
FDA
Spectrum Pharmaceuticals
Evomela
Multiple Myeloma
Flag link:
Two Biotechs Worth A Look Ahead Of FDA Approvals
Two Biotechs Worth A Look Ahead Of FDA Approvals
Investopedia
FDA
BioDelivery Sciences
Belbuca
chronic pain
Spectrum Pharmaceuticals
Evomela
Flag link:
Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs
Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs
FDA Law Blog
Otsuka
Abilify
orphan drugs
exclusivity
Fusilev
Spectrum Pharmaceuticals
Flag link:
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
FDA Law Blog
FDA
Hatch Waxman Act
Spectrum Pharmaceuticals
Boehringer Ingelheim
Otsuka
Flag link:
Spectrum Pharma reports 4Q loss
Spectrum Pharma reports 4Q loss
Yahoo/AP
Spectrum Pharmaceuticals
earnings
Flag link:
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Flag link:
Spectrum submits blood-cancer drug for FDA approval
Spectrum submits blood-cancer drug for FDA approval
Marketwatch
Spectrum Pharmaceuticals
FDA
CE-Melphalan
Multiple Myeloma
Ligand Pharmaceuticals
Flag link:
FDA approves Spectrum Pharma's blood cancer drug
FDA approves Spectrum Pharma's blood cancer drug
Yahoo/Reuters
FDA
Spectrum Pharmaceuticals
Beleodaq
peripheral T-cell lymphoma
Flag link:
Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
Why This Little-Known Biotech Is An Enticing Takeover And New-Products Play
Forbes
Spectrum Pharmaceuticals
Flag link:
Spectrum Pharma Up on Q1 Earnings
Spectrum Pharma Up on Q1 Earnings
Yahoo/Zacks.com
Spectrum Pharmaceuticals
earnings
Flag link:
Spectrum Pharma's cancer drug meets main goal in trial
Spectrum Pharma's cancer drug meets main goal in trial
Yahoo/Reuters
Spectrum Pharmaceuticals
melphalan
Multiple Myeloma
Flag link:
The 10 Most Heavily Shorted Bio-Pharma Stocks
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Spectrum Pharmaceuticals
Dendreon
Achillion
Ziopharm
Intrexon
Arena Pharmaceuticals
Idenix
Synta Pharmaceuticals
Sarepta Therapeutics
Myriad Genetics
Flag link:
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
Motley Fool
Nektar
Omeros
Spectrum Pharmaceuticals
Flag link:
The Zacks Analyst Blog Highlights: Gilead, Cytokinetics, Puma, Biogen and Spectrum Pharmaceuticals
The Zacks Analyst Blog Highlights: Gilead, Cytokinetics, Puma, Biogen and Spectrum Pharmaceuticals
Yahoo/Zacks.com
Gilead Sciences
Cytokinetics
Puma Biotechnology
Biogen Idec
Spectrum Pharmaceuticals
Flag link:
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Spectrum rises after saying FDA will make a decision on its lymphoma drug Beleodaq by Aug. 9
Yahoo/Reuters
Spectrum Pharmaceuticals
FDA
Beleodaq
T-cell lymphoma
Flag link:
Spectrum Pharmaceuticals Won’t Always Disappoint, RBC Says
Spectrum Pharmaceuticals Won’t Always Disappoint, RBC Says
Barron's
Spectrum Pharmaceuticals
Flag link:
Is Pessimism Warranted for These 3 Most Hated Biotech Stocks?
Is Pessimism Warranted for These 3 Most Hated Biotech Stocks?
Motley Fool
Dendreon
Sarepta Therapeutics
Spectrum Pharmaceuticals
Flag link: